Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00522392
What this trial is testing

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 48
Early research (Phase 1)Study completedNCT00992758
What this trial is testing

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Non Hodgkin's Lymphoma (NHL) Patients With Greater Than 25% Bone Marrow Involvement

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 11
Testing effectiveness (Phase 2)Study completedNCT00001155
What this trial is testing

Treatment of Wegener's Granulomatosis With Cyclophosphamide

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT00354926
What this trial is testing

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Applied Molecular Evolution 67
Testing effectiveness (Phase 2)Study completedNCT00418535
What this trial is testing

Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
Samsung Medical Center
Testing effectiveness (Phase 2)Study completedNCT03814317
What this trial is testing

Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension

Who this might be right for
SarcoidosisPrecapillary Pulmonary HypertensionInterstitial Lung Disease
University of Florida 5
Testing effectiveness (Phase 2)Temporarily pausedNCT05861050
What this trial is testing

Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma

Who this might be right for
Blastoid Variant Mantle Cell LymphomaMantle Cell LymphomaPleomorphic Variant Mantle Cell Lymphoma
City of Hope Medical Center 50
Not applicableStudy completedNCT05284591
What this trial is testing

Non-interventional Study to Evaluate Patient and Healthcare Provider Satisfaction of Daratumumab Use in the Treatment of First-line Daratumumab, Lenalidomide, Dexamethasone (DRd) Multiple Myeloma Patients in Germany Depending on Application Route (sc or iv)

Who this might be right for
Multiple MyelomaNewly DiagnosedTransplant Ineligible+3 more
iOMEDICO AG 96
Early research (Phase 1)WithdrawnNCT02095574
What this trial is testing

A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Non-Hodgkin's Lymphoma
AbbVie
Post-approval studies (Phase 4)Study completedNCT00114348
What this trial is testing

ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Lymphoblastic Leukemia, AcuteLymphoma, Non-Hodgkin
Charite University, Berlin, Germany 338
Testing effectiveness (Phase 2)UnknownNCT03679455
What this trial is testing

Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1

Who this might be right for
Waldenstrom Macroglobulinemia
Polish Myeloma Consortium 30
Testing effectiveness (Phase 2)Study completedNCT02751255
What this trial is testing

Daratumumab in Combination With ATRA

Who this might be right for
Multiple Myeloma
Amsterdam UMC, location VUmc 60
Testing effectiveness (Phase 2)Ended earlyNCT04788043
What this trial is testing

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaClassic Hodgkin LymphomaRelapsed Classical Hodgkin Lymphoma+1 more
Ranjana Advani 8
Testing effectiveness (Phase 2)UnknownNCT05880043
What this trial is testing

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

Who this might be right for
Advanced Solid TumorsRelapsed/Refractory Non-Hodgkin LymphomaRelapsed/Refractory Multiple Myeloma
GI Cell, Inc. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT03914625
What this trial is testing

Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaB Lymphoblastic LymphomaDown Syndrome
National Cancer Institute (NCI) 6,720
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Large-scale testing (Phase 3)Study completedNCT00129090
What this trial is testing

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)
German High-Grade Non-Hodgkin's Lymphoma Study Group 450
Not applicableStudy completedNCT01131208
What this trial is testing

Biomarkers in Patients With Diffuse Large B-Cell Lymphoma Treated With Combination Chemotherapy With or Without Rituximab

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)UnknownNCT05320640
What this trial is testing

Study of Chidamide, Decitabine and Immune Checkpoint Inhibitors in R/R NHL and Advanced Solid Tumors

Who this might be right for
Relapsed/Refractory Non-Hodgkin LymphomaAdvanced Solid Tumors
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05841550
What this trial is testing

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital 20
Next Page